SCHEMBL5754375

SCHEMBL5754375

COCC[CH]O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10899490 0.81
SCHEMBL10418479 0.79
SCHEMBL15593683 0.75
SCHEMBL11319609 0.72 LPAR3 (0.30)
SCHEMBL310640 0.72
SCHEMBL7773058 0.72 LPAR3 (0.30)
SCHEMBL778646 0.69
Formic Acid SCHEMBL28261917 0.69
SCHEMBL6055740 0.69
SCHEMBL8133406 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3835306-A1 MICROWAVE-ASSISTED METHOD FOR SYNTHESIS OF OLIGO- AND POLYSACCHARIDES ON SOLID PHASE Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-06-16 EP claimed
US-6815449-B2 AN IMMUNOSUPPRESSANTS FOR TREATING AUTOIMMUNE DISEASES, ANTIALLERGIC AGENTS, ANTITUMOR AGENTS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-11-09 US claimed
EP-1097934-B1 LK6-A DERIVATIVES KYOWA HAKKO KOGYO KK (JP) 2004-10-13 EP claimed
US-20030181722-A1 LK6-A derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-09-25 US claimed
US-6613774-B1 Alkaloids used as immunosuppressants, antiproliferative or antitumor agents for therapy of autoimmune diseases or allergies KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-09-02 US claimed
EP-1097934-A1 LK6-A DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-05-09 EP claimed
JP-6211809-A None JP disclosed
CN-110114358-B Novel compound and pharmacologically acceptable salt thereof 明治制果药业株式会社 2021-12-03 CN disclosed
US-20210315892-A1 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-10-14 US disclosed
CN-107709301-B Pyrazole derivative or pharmacologically acceptable salt thereof 橘生药品工业株式会社 2021-06-22 CN disclosed
EP-3560925-B1 NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF MEIJI SEIKA PHARMA CO LTD (JP) 2021-06-02 EP disclosed
EP-3815687-A1 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES Meiji Seika Pharma Co., Ltd. (JP) 2021-05-05 EP disclosed
CN-112312914-A Therapeutic agent for inflammatory disease, autoimmune disease, fibrotic disease, and cancer disease 明治制果药业株式会社 2021-02-02 CN disclosed
US-6586106-B2 Ink transfer, adhesion and aging stability, and being satisfactory in back ghost when offset printing using oxidation polymerization type ink is performed on both faces YUPO CORPORATION (JP) 2003-07-01 US disclosed
US-20020054991-A1 Thermoplastic resin film satisfactory in printability YUPO CORPORATION (JP) 2002-05-09 US disclosed
EP-1172400-A1 THERMOPLASTIC RESIN FILM WITH SATISFACTORY PRINTABILITY Yupo Corporation (JP) 2002-01-16 EP disclosed
EP-1097934-A1 LK6-A DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-05-09 EP disclosed
JP-H06211809-A 2-AMINOPYRIMIDINE-4-CARBOXAMIDE DERIVATIVE SYNTHELABO SA 1994-08-02 JP disclosed
US-4475943-A Herbicidal α-hydroxy phosphonates MONSANTO COMPANY (US) 1984-10-09 US disclosed
US-4413125-A α-Hydroxy phosphonates MONSANTO COMPANY (US) 1983-11-01 US disclosed